Association of Adiponectin Polymorphism with Metabolic Syndrome Risk and Adiponectin Level with Stroke Risk: A Meta-Analysis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yuan, Hui Ping ^a   Sun, Liang ^a   Li, Xing Hui ^a   Che, Fu Gang ^a   Zhu, Xiao Quan ^a   Yang, Fan ^a   Han, Jing ^a   Jia, Chun Yuan ^a   Yang, Ze ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

BLOOD; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; META ANALYSIS; METABOLIC DISORDER; METABOLIC SYNDROME X; ODDS RATIO; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METABOLIC DISEASES; METABOLIC SYNDROME; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STROKE;

EID: 84986199797     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31945     Document Type: Article

References (63)

1. Kaur, J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 943162 (2014).
2. Taylor, J. Y. et al. An overview of the genomics of metabolic syndrome. J Nurs Scholarsh 45(1), 52-59 (2013).
3. Gu, H. F. et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 53 Suppl 1, S31-S35 (2004).
4. Stumvoll, M. et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51(1), 37-41 (2002).
5. Henneman, P. et al. Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care 33(4), 908-913 (2010).
6. Ruan, H. & Dong, L. Q. Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol. [Epub ahead of print] (2016).
7. Chu, H. et al. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. Diabetes Metab Res Rev 29(7), 532-545 (2013).
8. Melistas, L. et al. Association of the + 45T> G and + 276G > T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol 161(6), 845-852 (2009).
9. Gao, M. et al. Association of genetic variants in the adiponectin gene with metabolic syndrome: a case-control study and a systematic meta-analysis in the Chinese population. PLoS One 8(4), e58412 (2013).
10. Kanhai, D. A. et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies. Obes Rev 14(7), 555-567 (2013).
11. Arregui, M. et al. Adiponectin and risk of stroke: prospective study and meta-analysis. Stroke 45(1), 10-17 (2014).
12. Hao, G. et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. Atherosclerosis 228(1), 29-35 (2013).
13. Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7), e1000097 (2009).
14. Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7), e1000100 (2009).
15. Wells, G. A., D O'Connell, B. S., Peterson, J., Welch, V., Losos, M. & Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: www. ohri. ca/programs/clinical-epidemiology/oxford. asp. (Accessed: 1st May 2016) (2011).
16. Li, K. et al. Association of two polymorphisms rs2910164 in miRNA-146a and rs3746444 in miRNA-499 with rheumatoid arthritis: a meta-analysis. Hum Immunol 75(7), 602-608 (2014).
17. Qiu, M. T. et al. Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One 7(12), e50887 (2012).
18. Yuan, H. et al. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab 100(11), 4198-4207 (2015).
19. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21(11), 1539-1558 (2002).
20. Higgins JPT, G. S. e., Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 [updated March 2011]. The Cochrane Collaboration, Available at: www. cochrane-handbook. org. (Accessed: 1st May 2016) (2011).
21. Wang, S. J., Jia, W. P., Bao, Y. Q. & JQ, L. Association of adiponectin gene polymorphism with metabolic syndrome. J Chinese Practical Diagnosis and Therapy 26(7), 659-661 (2012).
22. Yao, M. Diploma Thesis, Chinese Academy of Medical Science & Peking Union Medical College, 2004.
23. Liu, D. X., Hua, Q. i., Guo, J. C. & Liu, R. K. Difference of adiponectin gene exon 2 Glyl5Gly genotype and allele frequency between patients with metabolic syndrome and normal persons. Chin J Clin Rehabilitation 10(6), 4-6 (2006).
24. Li, Y. P. et al. Adiponectin gene SNP11377 and SNP-4522 haplotypes are related to metabolic syndrome. Basic Clin Med 30(12), 1288-1292 (2010).
25. Zhu, X. W. et al. Studies on adiponectin gene polymorphisms in patients with metabolic syndrome. Shandong Med J 50(29), 10-12 (2010).
26. Cai, Q., Liu, H. J., Chen, T. & MC, Z. Mononucleotide polymorphism at + 45 and + 276 site of adiponectin gene in aircrew with metabolic syndrome. Clin J Med Officers 38(5), 813-815 (2010).
27. Ranjith, N., Pegoraro, R. J. & Shanmugam, R. Obesity-associated genetic variants in young Asian Indians with the metabolic syndrome and myocardial infarction. Cardiovasc J Afr 22(1), 25-30 (2011).
28. Bu, R. F. et al. The association of adiponectin gene polymorphism and serum adiponectin level with metabolic syndrome in older. Chin J Gerontology 31, 4112-4114 (2011).
29. Leu, H. B. et al. Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 6(5), e19999 (2011).
30. Huang, F. Z., Liu, J., Pang, D. & PL, B. The association of adiponectin gene SNP + 276 and SNP + 45 with metabolic syndrome. Chinese J of Endocrinology and Metabolism 28(11), 911-913 (2012).
31. Li, X. T. et al. Association of the adiponectin gene (ADIPOQ) + 45 T. G polymorphism with the metabolic syndrome among Han Chinese in Sichuan province of China. Asia Pac J Clin Nutr 21(2), 296-301 (2012).
32. Chen, F. et al. Study on the correlation of adiponectin gene polymorphism and coronary heart disease in the patients with metabolic syndrome in Han nationlity population in Ningxia. Clin J Crit Care Med 32(1), 24-29 (2012).
33. Shen, J. et al. Relation of metabolic syndrome with plasma adiponectin level and gene polymorphism in Ningxia Hui subjects. Chin J Geriatr Heart Brain Vessel Dis 15(1), 7-10 (2013).
34. Xu, J. et al. Association of adiponectin gene polymorphrism with metabolic syndrome in older Han adults from major cities in China. Journal of Hygiene Research 42(3), 353-359 (2013).
35. Suriyaprom, K., Phonrat, B. & Tungtrongchitr, R. Association of adiponectin gene-11377C > G polymorphism with adiponectin levels and the metabolic syndrome in Thais. Asia Pac J Clin Nutr 23(1), 167-173 (2014).
36. Soderberg, S. et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256(2), 128-136 (2004).
37. Matsumoto, M., Ishikawa, S. & Kajii, E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 39(2), 323-328 (2008).
38. Stott, D. J. et al. Adipocytokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 38(1), 253-261 (2009).
39. Ogorodnikova, A. D. et al. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study. Stroke 41(7), 1376-1381 (2010).
40. Khalili, P. et al. Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study. Diabetes Metab 36(2), 137-143 (2010).
41. Rajpathak, S. N. et al. Resistin, but not adiponectin and leptin, is associated with the risk of ischemic stroke among postmenopausal women: results from the Women's Health Initiative. Stroke 42(7), 1813-1820 (2011).
42. Prugger, C. et al. Adipocytokines and the risk of ischemic stroke: the PRIME Study. Ann Neurol 71(4), 478-486 (2012).
43. Wannamethee, S. G. et al. Adiposity, adipokines, and risk of incident stroke in older men. Stroke 44(1), 3-8 (2013).
44. Gardener, H. et al. Adiponectin and risk of vascular events in the Northern Manhattan study. Atherosclerosis 226(2), 483-489 (2013).
45. Bidulescu, A. et al. Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans: the jackson heart study. Front Public Health 1, 16 (2013).
46. Kizer, J. R. et al. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab 98(1), 255-263 (2013).
47. Scherer, P. E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55(6), 1537-1545 (2006).
48. Santaniemi, M., Kesaniemi, Y. A. & Ukkola, O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 155(5), 745-750 (2006).
49. Vasseur, F. et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11(21), 2607-2614 (2002).
50. Prakash, J., Mittal, B., Awasthi, S. & Srivastava, N., Association of adiponectin gene polymorphism with adiponectin levels and risk for insulin resistance syndrome. Int J Prev Med 6, 31 (2015).
51. Guzman-Ornelas, M. O. et al. Association of ADIPOQ + 45T > G polymorphism with body fat mass and blood levels of soluble adiponectin and inflammation markers in a Mexican-Mestizo population. Diabetes Metab Syndr Obes 5, 369-378 (2012).
52. Wu, J., Liu, Z., Meng, K. & Zhang, L. Association of adiponectin gene (ADIPOQ) rs2241766 polymorphism with obesity in adults: a meta-analysis. PLoS One 9(4), e95270 (2014).
53. BC, Z., WJ, L., WL, C. & YW, X. Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta-analysis of 17 case-control studies. Clin Endocrinol (Oxf) 77(3), 370-378 (2012).
54. Thompson, S. G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 309(6965), 1351-1355 (1994).
55. Munafo, M. R. & Flint, J. Meta-analysis of genetic association studies. Trends Genet 20(9), 439-444 (2004).
56. Fan, Y. et al. Association between ADIPOQ + 45T> G polymorphism and type 2 diabetes: a systematic review and meta-analysis. Int J Mol Sci 16(1), 704-723 (2015).
57. Vimaleswaran, K. S. et al. A novel association of a polymorphism in the first intron of adiponectin gene with type 2 diabetes, obesity and hypoadiponectinemia in Asian Indians. Hum Genet 123(6), 599-605 (2008).
58. Fan, Y. et al. Association between ADIPOQ + 45T> G polymorphism and type 2 diabetes: a systematic review and meta-analysis. Int J Mol Sci 16(1), 704-723 (2014).
59. Valderas, J. M. et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 7(4), 357-363 (2009).
60. Jakovljevic, M. & Ostojic, L. Comorbidity and multimorbidity in medicine today: challenges and opportunities for bringing separated branches of medicine closer to each other. Psychiatr Danub 25 Suppl 1, 18-28 (2013).
61. Stern, M. P. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44(4), 369-374 (1995).
62. Heid, I. M. et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 208(2), 412-420 (2010).
63. Cnop, M. et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46(4), 459-469 (2003).